✦ LIBER ✦

Transdermal Rotigotine: A Clinically Innovative Dopamine-Receptor Agonist for the Management of Parkinson's Disease

✍ Scribed by Dr. Jack J. Chen; Dr. David M. Swope; Dr. Khashayar Dashtipour; Dr. Kelly E. Lyons

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transdermal rotigotine for the periopera

✍ Ullrich Wüllner; Jan Kassubek; Per Odin; Michael Schwarz; Markus Naumann; Herman 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 144 KB

A.2 The preclinical profile of rotigotin

✍ P. Jenner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A.3 Rotigotine (Neupro®), a new non-ergo

✍ N. Giladi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The in vitro receptor profile of rotigot

✍ Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lüb 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 393 KB

Clinical and pharmacogenetic determinant

✍ Maurits E. L. Arbouw; Kris L. L. Movig; Toine C. G. Egberts; Petra J. E. Poels; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 117 KB

Proterguride, a highly potent dopamine r

✍ B. Schurad; R. Horowski; S. Jähnichen; T. Görnemann; J. Tack; H.H. Pertz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 154 KB